Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma is a research paper published in Journal of Clinical Investigation (2021). On theSindex it has a DataRank of 0. It has been cited 35 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Israel Science Foundation
Grant: 696/17
H2020 European Research Council
Grant: 770854
An integrative approach for the exploration of melanoma genetic and immunological interactions
Israel Science Foundation
Grant: 494/16
NCI NIH HHS
Grant: K08 CA230188
Medical Research Council
Grant: MR/V000292/1
European Research Council
Grant: 622106
European Research Council
Grant: 754282
NIAID NIH HHS
Grant: T32 AI007290
National Institutes of Health
Grant: 5T32AI007290-27
Molecular and Cellular Immunobiology
National Health and Medical Research Council (NHMRC)
Grant: 1093017
Molecular determinants of risk, progression and treatment response in melanoma
National Health and Medical Research Council (NHMRC)
Grant: 1141295
Improving clinical outcomes of melanoma patients
Wellcome Trust
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5K08CA230188-03
Single cell epigenomics in cancer immunity and immunotherapy
FWCI
1.61
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals